J. Wilson and G. Jungner, Principles and Practice of Mass Screening for Disease In Public Health Papers, Geneva: WHO, p.34, 1968.

F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, and A. Woronoff, Estimation Nationale de l'incidence et de la Mortalité par Cancer en France entre 1980 et 2012, Partie 1 ? Tumeurs Solides. InVS, 2013.

A. Belot, P. Grosclaude, N. Bossard, E. Jougla, and E. Benhamou, Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-175, 1980.
DOI : 10.1016/j.respe.2008.03.117

URL : https://hal.archives-ouvertes.fr/hal-00538673

. Hauteautoritedesanté, La Participation au Dépistage du Cancer du sein chez les Femmes de 50 à 74 ans en France: Situation Actuelle et Perspectives d'évolution. In Saint-Denis, 2011.

. Inca, Les Français face au Dépistage des Cancers In Collection Enquêtes et Sondages. Edited by INCa, 2009.

N. Duport, R. Ancelle-park, M. Boussac-zarebska, Z. Uhry, and J. Bloch, Are breast cancer screening practices associated with sociodemographic status and healthcare access? Analysis of a French cross-sectional study, European Journal of Cancer Prevention, vol.17, issue.3, pp.218-224, 2008.
DOI : 10.1097/CEJ.0b013e3282b6fde5

K. Mcpherson, Should we screen for breast cancer?, BMJ, vol.2010, issue.3417767, p.233

P. Gøtzsche and K. Jørgensen, Screening for breast cancer with mammography, Cochrane Database Syst Rev, vol.6, p.1877, 2013.

P. Gøtzsche and O. Olsen, Is screening for breast cancer with mammography justifiable? Lancet, pp.129-134, 2000.

O. Olsen and P. Gøtzsche, Cochrane review on screening for breast cancer with mammography, The Lancet, vol.358, issue.9290, pp.1340-1342, 2001.
DOI : 10.1016/S0140-6736(01)06449-2

H. Nelson, K. Tyne, A. Naik, C. Bougatsos, B. Chan et al., Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force, Annals of Internal Medicine, vol.151, issue.10, pp.727-737, 2009.
DOI : 10.7326/0003-4819-151-10-200911170-00009

R. Peto, J. Boreham, M. Clarke, and C. Davies, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20?69 years, Lancet, issue.9217, p.3551822, 2000.

K. Jørgensen, P. Zahl, and P. Gøtzsche, Breast cancer mortality in organised mammography screening in Denmark: comparative study, BMJ, vol.340, issue.mar23 1, p.1241, 2010.
DOI : 10.1136/bmj.c1241

M. Kalager, M. Zelen, F. Langmark, and H. Adami, Effect of Screening Mammography on Breast-Cancer Mortality in Norway, New England Journal of Medicine, vol.363, issue.13, pp.1203-1210, 2010.
DOI : 10.1056/NEJMoa1000727

P. Autier, M. Boniol, A. Gavin, and L. Vatten, Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database, BMJ, vol.343, issue.jul28 1, p.4411, 2011.
DOI : 10.1136/bmj.d4411

. Bosettic, . Bertucciop, . Levif, . Chatenoudl, and L. Negrie, The decline in breast cancer mortality in Europe: An update (to 2009), The Breast, vol.21, issue.1, pp.77-82, 2011.
DOI : 10.1016/j.breast.2011.08.001

R. Burton, R. Bell, G. Thiagarajah, and C. Stevenson, Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991, Breast Cancer Research and Treatment, vol.340, issue.3, pp.949-955
DOI : 10.1007/s10549-011-1794-6

M. Marmot, D. Altman, D. Cameron, J. Dewar, and S. Thompson, The benefits and harms of breast cancer screening: an independent review, British Journal of Cancer, vol.15, issue.11
DOI : 10.1136/jech.2008.083774

A. Seigneurin, O. François, J. Labarère, P. Oudeville, and J. Monlon, Overdiagnosis from non-progressive cancer detected by screening mammography, pp.1472-693964
URL : https://hal.archives-ouvertes.fr/hal-00655074

D. Puliti, S. Duffy, G. Miccinesi, H. De-koning, and E. Lynge, Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review, Journal of Medical Screening, vol.118, issue.1_suppl, pp.42-56
DOI : 10.2307/2530739

P. Gøtzsche and K. Jørgensen, The benefits and harms of breast cancer screening, Lancet, vol.2013, issue.93819869, p.799

K. Jørgensen and P. Gøtzsche, Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends, BMJ, vol.339, issue.jul09 1, pp.339-2587, 2009.
DOI : 10.1136/bmj.b2587

S. Hofvin, A. Ponti, J. Patnick, N. Ascunce, and S. Njor, False-Positive Results in Mammographic Screening for Breast Cancer in Europe: A Literature Review and Survey of Service Screening Programmes, Journal of Medical Screening, vol.18, issue.13, pp.57-66, 2012.
DOI : 10.1258/jms.2012.012083

A. Seigneurin, C. Exbrayat, J. Labarère, and M. Colonna, Comparison of interval breast cancer rates for two-versus single-view screening mammography: A population-based study, The Breast, vol.18, issue.5, pp.284-288, 2009.
DOI : 10.1016/j.breast.2009.07.007

URL : https://hal.archives-ouvertes.fr/inserm-00449273

M. Solbjør, J. Skolbekken, A. Saetnan, A. Hagen, and S. Forsmo, Mammography screening and trust: The case of interval breast cancer, Social Science & Medicine, vol.75, issue.10, pp.751746-1752
DOI : 10.1016/j.socscimed.2012.07.029

M. Yaffe and J. Mainprize, Risk of Radiation-induced Breast Cancer from Mammographic Screening, Radiology, vol.258, issue.1, pp.98-105, 2011.
DOI : 10.1148/radiol.10100655

D. Preston, A. Mattsson, E. Holmberg, R. Shore, and N. Hildreth, Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts, Radiation Research, vol.158, issue.2, pp.220-235, 2002.
DOI : 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2

J. Hersch, J. Jansen, A. Barratt, L. Irwig, and N. Houssami, Women's views on overdiagnosis in breast cancer screening: a qualitative study, BMJ, vol.346, issue.jan23 1, pp.158-158, 2013.
DOI : 10.1136/bmj.f158

L. Giordano, C. Cogo, J. Patnick, and E. Paci, Communicating the Balance Sheet in Breast Cancer Screening, Journal of Medical Screening, vol.45, issue.1_suppl, pp.67-71
DOI : 10.1258/jms.2012.012084

J. Morère, X. Pivot, J. Viguier, and J. Blay, Calazel-Benque A: Breast cancer screening in women aged 50?74 years: is there room for improvement? Eur J Canc, pp.8-12, 2011.

N. Hawkes, Women "jurors" are asked how to present risk-benefit ratio of breast cancer screening, BMJ, vol.345, issue.nov22 3, p.7886
DOI : 10.1136/bmj.e7886

T. Beauchamp and J. Childress, Principles of Biomedical Ethics, International Clinical Psychopharmacology, vol.6, issue.2, 1979.
DOI : 10.1097/00004850-199100620-00013

M. Marzano, Place du consentement dans les relations entre m??decins et patients??: un point de vue philosophique, La Presse M??dicale, vol.42, issue.1, pp.6-12, 2013.
DOI : 10.1016/j.lpm.2012.07.018

R. Jepson, J. Hewison, A. Thompson, and D. Weller, Patient perspectives on information and choice in cancer screening: A qualitative study in the UK, Social Science & Medicine, vol.65, issue.5, pp.890-899, 2007.
DOI : 10.1016/j.socscimed.2007.04.009

S. Gravel, H. Doucet, A. Battaglini, D. Laudy, M. Bouthillier et al., Éthique et santé publique: Quelle place pour l'autonomie? Ethique publique, pp.1226-1250, 2010.

. Swiss-medical and . Board, Systematic Mammography Screening In http://www. medical-board.ch/fileadmin

N. Biller-andorno and P. Jüni, Abolishing mammography screening programs? A View from the Swiss Medical Board, N Engl J Med, vol.2014, issue.37021, pp.1965-1967